Horus University
Clinical trials sponsored by Horus University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could exercise reshape gut bacteria in fatty liver disease? Results expected Sep 2026 (estimated)
- Could a COPD drug ease rheumatoid arthritis? Results expected Oct 2026 (estimated)
- Can pilates or HIIT boost lung fitness in asthma? Results expected Nov 2026 (estimated)
- New injection could ease jaw pain better than standard treatment Results expected Nov 2026 (estimated)
- Allergy drug could help rheumatoid arthritis patients Results expected Nov 2026 (estimated)
-
Wisdom tooth graft showdown: donor vs. Patient's own dentin
Disease control Recruiting nowThis study tests whether a donor tooth-derived bone graft works as well as a patient's own tooth graft for preserving jawbone after impacted wisdom tooth extraction. Forty adults with similar impacted wisdom teeth on both sides of the jaw will receive one graft type per side. Res…
Sponsor: Horus University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a COPD drug ease rheumatoid arthritis?
Disease control Recruiting nowThis study tests whether adding roflumilast to standard treatment can reduce joint pain and swelling in people with active rheumatoid arthritis. About 50 adults aged 18-60 will take either roflumilast or a placebo for 12 weeks. Researchers will measure changes in disease activity…
Phase 2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Allergy drug could help rheumatoid arthritis patients
Disease control Recruiting nowThis phase 2 trial is testing whether adding desloratadine, an allergy medication, to standard rheumatoid arthritis therapy can reduce joint inflammation and disease activity. Sixty adults with active RA will receive either desloratadine or a placebo for 12 weeks. The study measu…
Phase 2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could allergy and COPD drugs tame rheumatoid arthritis?
Disease control Recruiting nowThis study tests whether adding either roflumilast (a COPD drug) or desloratadine (an allergy drug) to standard rheumatoid arthritis treatment can better control the disease. About 90 adults with active RA will take one of these drugs or a placebo for 12 weeks. The goal is to see…
Phase 2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New injection could ease jaw pain better than standard treatment
Symptom relief Recruiting nowThis study compares a new injection of liquid phase concentrated growth factor (LPCGF) to standard arthrocentesis (joint washing) for people with painful jaw clicking and limited mouth opening due to a displaced disc. Thirty-two adults aged 18-45 with unilateral disc displacement…
Sponsor: Horus University • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC